Related Experiment Video
Updated: Aug 20, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Elizabethkingia meningoseptica Infection in COVID-19 Patients
Mas Chaponda1, Adila Shaukat1, Mohammad Wajeh Dulli2
1Infectious Diseases Department, Hamad Medical Corporation, Doha, QAT.
Abstract:
Bacterial and fungal coinfections including the emergence of antimicrobial resistance are well-recognized in the era of coronavirus disease 2019 (COVID-19) infections. We present three cases of Elizabethkingia meningoseptica (EM), superinfections in COVID-19 patients admitted between the period of April 2021 and May 2021. All cases were intubated; had central venous catheters, had received prior antibiotics and antivirals as well as dexamethasone as part of severe COVID-19 management. Only one patient received anakinra. EM isolates were resistant to most available antibiotics and patients infected with it had poor treatment outcomes.
Insights
Coinfections with Elizabethkingia meningoseptica (EM) are emerging in severe COVID-19 patients. These superinfections show high antimicrobial resistance, leading to poor patient outcomes.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- The COVID-19 pandemic has seen an increase in bacterial and fungal coinfections.
- Antimicrobial resistance is a growing concern in managing severe COVID-19 cases.
Observation:
- Three cases of Elizabethkingia meningoseptica (EM) superinfections in COVID-19 patients are presented.
- These patients were critically ill, intubated, and had central venous catheters.
- They received extensive prior treatment including antibiotics, antivirals, and dexamethasone.
Findings:
- Elizabethkingia meningoseptica isolates demonstrated resistance to most tested antibiotics.
- All three patients experienced poor treatment outcomes.
Implications:
- This highlights the need for vigilance regarding unusual bacterial superinfections in severe COVID-19.
- Emergence of multidrug-resistant EM poses a significant challenge in critical care settings.
- Further research into optimal management strategies for EM superinfections in immunocompromised patients is warranted.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis

